Key points are not available for this paper at this time.
Figure S6 shows SpiD3 inhibits NF-κB activity and diminishes CD40L-induced survival signaling in CLL.
Eiken et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: